Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page
- Check4 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No substantive core content appears to have changed.SummaryDifference0.7%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.7%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference18%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check40 days agoChange DetectedThe web page has been updated to a new version, v2.16.11, and the previous version, v2.16.10, has been removed. Additionally, a date of 2025-08-07 has been added.SummaryDifference1.0%
- Check47 days agoChange DetectedThe page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.